文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症呼吸衰竭与机械通气

中国重型危重型新型冠状病毒肺炎(COVID-19)患者的临床特征与结局:一项回顾性多中心研究

Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study.
PubMed 文献 · Intensive Care Med · 2020-08-20
一句话结论中国19家医院733例危重型COVID-19患者28天死亡率为53.8%,年龄、恶性肿瘤、高APACHE II评分、高D-二聚体、低PaO2/FiO2、高肌酐、高hscTnI和低白蛋白为独立危险因素。

该回顾性多中心研究纳入2020年1月1日至2月29日中国19家医院733例实验室确诊的危重型COVID-19成人患者,描述其临床特征并分析死亡危险因素。患者中位年龄65岁(IQR 56-73),女性占34.9%,中位APACHE II评分10分(IQR 7-14),28天死亡率为53.8%。呼吸衰竭是最常见的器官衰竭(81.5%),其次是休克(20%)、血小板减少(18.8%)、中枢神经系统功能障碍(8.6%)和肾功能不全(8%)。多因素Cox回归显示高龄、恶性肿瘤、高APACHE II评分、高D-二聚体水平、低PaO2/FiO2水平、高肌酐水平、高hscTnI水平和低白蛋白水平是28天死亡的独立危险因素。

要点

  • 733例危重型COVID-19成人患者28天死亡率为53.8%,超过半数患者死亡。
  • 呼吸衰竭是最常见的器官衰竭(597例,81.5%),其次为休克(20%)、血小板减少(18.8%)、中枢神经系统功能障碍(8.6%)和肾功能不全(8%)。
  • 多因素Cox回归显示高龄、恶性肿瘤、高APACHE II评分、高D-二聚体、低PaO2/FiO2、高肌酐、高hscTnI和低白蛋白是28天死亡的独立危险因素。
  • 患者中位年龄65岁(IQR 56-73),女性占34.9%,中位APACHE II评分为10分(IQR 7-14)。

适用人群与场景

  • 中国19家医院收治的实验室确诊COVID-19危重型成人患者,数据收集时间为2020年1月1日至2月29日。

研究设计与关键结果

  • 回顾性多中心研究,纳入733例危重型COVID-19成人患者,来自中国19家医院。
  • 主要结局28天死亡率为53.8%。
  • 呼吸衰竭是最常见的器官衰竭(597例,81.5%),其次为休克(20%)、血小板减少(18.8%)、中枢神经系统功能障碍(8.6%)和肾功能不全(8%)。
  • 多因素Cox回归分析显示,高龄、恶性肿瘤、高APACHE II评分、高D-二聚体水平、低PaO2/FiO2水平、高肌酐水平、高hscTnI水平和低白蛋白水平是28天死亡的独立危险因素。

证据类型、等级与局限

  • 证据类型:回顾性多中心病例系列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,危重型COVID-19患者中器官衰竭比例较高,提示对重症监护资源有显著需求。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: An ongoing outbreak of coronavirus disease 2019 (COVID-19) emerged in Wuhan since December 2019 and spread globally. However, information about critically ill patients with COVID-19 is still limited. We aimed to describe the clinical characteristics and outcomes of critically ill patients with COVID-19 and figure out the risk factors of mortality.

METHODS: We extracted data retrospectively regarding 733 critically ill adult patients with laboratory-confirmed COVID-19 from 19 hospitals in China through January 1 to February 29, 2020. Demographic data, symptoms, laboratory values, comorbidities, treatments, and clinical outcomes were collected. The primary outcome was 28-day mortality. Data were compared between survivors and non-survivors.

RESULTS: Of the 733 patients included in the study, the median (IQR) age was 65 (56-73) years and 256 (34.9%) were female. Among these patients, the median (IQR) APACHE II score was 10 (7 to 14) and 28-day mortality was 53.8%. Respiratory failure was the most common organ failure (597 [81.5%]), followed by shock (20%), thrombocytopenia (18.8%), central nervous system (8.6%) and renal dysfunction (8%). Multivariate Cox regression analysis showed that older age, malignancies, high APACHE II score, high D-dimer level, low PaO2/FiO2 level, high creatinine level, high hscTnI level and low albumin level were independent risk factors of 28-day mortality in critically ill patients with COVID-19.

CONCLUSION: In this case series of critically ill patients with COVID-19 who were admitted into the ICU, more than half patients died at day 28. The higher percentage of organ failure in these patients indicated a significant demand for critical care resources.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Xie J, Wu W, Li S, et al. Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study. Intensive Care Med. 2020. PMID: 32816098. doi:10.1007/s00134-020-06211-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。